Labomar invests €10 million in Research & Development and unveils the new Mucowall® patent
Labomar Group strengthens its role as an innovator in the nutraceutical sector by announcing a three-year plan worth €10 million dedicated to Research & Development. With 19 active patents and a team of 20 specialists in Research and Scientific Services, the Group reaffirms its strategy of continuous innovation, based on an integrated model with high scientific value.
Among the most recent results is a versatile technology applicable to various pharmaceutical forms and therapeutic areas. Mucowall adheres to mucous membranes to create a protective barrier, enhancing product effectiveness. This innovation reduces development time and costs, offering clients a tangible competitive advantage.
The new technology was previewed at Vitafoods Europe 2025, a key international showcase for the nutraceutical sector.
For more details, continue reading in the MEDIA section.
